The chart on Chewy is one ugly mutt, there's no denying it, but the price action turned this week.
September's wave of buying in value stocks likely helped lift some of the 12 companies that are part of the 2018 Tax-Loss Selling Recovery Portfolio.
Alexion Pharmaceuticals and Elanco Animal Health have seen their shares go to the dogs of late, but still offer reasons for portfolio consideration.
IDEXX Laboratories and Zoetis Inc. appear ready to trade higher, offering stable opportunities as the dog-eat-dog trade war lingers on.
Bruce's resume includes a number of finance-related roles at Big G as well as tenures at Ford Motor and Ecolab.
Here's how to play the stock right now.
Greenlight Capital's founder compares Chewy to dot-com bumble casualty Pets.com.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.